Plate Nº 42 · recorded November 6, 2026
Health & Medicine ResearchReported finding
UK Puts £52 Million Into Five Hubs That Aim to Catch Disease Early
Five new UK hubs backed by over £52 million will use AI to catch dementia, heart disease and diabetes years earlier — with £37.5 million more from industry partners.
By Nathan Brooks4 min read792 words
In brief
- UKRI is investing over £52 million in five healthcare innovation hubs, with partners adding £37.5 million more.
- The BRAINIAC hub will test AI across ten NHS sites with more than 1,700 patients, aiming for 50% faster dementia diagnosis.
- Cardiovascular disease affects over 7 million people in the UK and causes a quarter of all deaths.
- Respiratory infections drive around 25 million GP consultations and 850,000 hospital admissions a year in England.
- Life expectancy in parts of the North East and North Cumbria is up to 10 years shorter than elsewhere in England.

Five new research hubs will share more than £52 million from the UK government, through UK Research and Innovation (UKRI), to build technologies that detect illness years before symptoms show. Partners including Google, Siemens and Medtronic add another £37.5 million in cash and in-kind support, bringing total backing close to £90 million.
The investment builds on earlier healthcare hubs whose work already produced the world's first AI-assisted brain tumour surgery and spacesuits with artificial muscles for Moon and Mars missions.
What will the hubs actually build?
The five hubs, based in Exeter, London, Southampton and Sunderland, each have a concrete brief:
- BRAINIAC (University of Exeter, led by Professor David Llewellyn): the UK's first network of NHS brain health clinics. Ten sites will test AI that combines blood tests, brain scans and memory tests into one picture of brain health, involving more than 1,700 patients. The goal: cut dementia risk and make diagnosis up to 50% faster.
- BRAIN-SAFE (Imperial College London, led by Professor David Sharp): computer models that predict an individual's brain injury risk after a head impact, factoring in age, sex and previous injuries. Traumatic brain injury is the leading cause of death and disability in under-40s. Possible uses include real-time pitch-side alerts in sport, crash data that flags likely brain injury to paramedics, and safer helmets.
- HeartTech (King's College London, led by Professor Sebastien Ourselin): tools combining wearables, imaging and health records to spot cardiovascular risk earlier. Cardiovascular disease affects more than 7 million people in the UK and causes a quarter of all deaths. The hub will develop an AI wellbeing coach that nudges lifestyle changes and tells users when to see a clinician.
- CRISP (University of Southampton, led by Associate Professor Alexander Edwards): wearable sensors, smartphone apps that analyse coughs and breathing, and rapid home tests. Acute respiratory infections drive around 25 million GP consultations and 850,000 hospital admissions a year in England. AI would combine the data to predict how an illness develops and tell people whether to rest or contact a pharmacist or GP.
- NORI (University of Sunderland, led by Professor Matthew Campbell): AI that reads routine eye scans for early signs of diabetes and heart disease, starting at Sunderland Specialist Eye Hospital.
Why eyes?
The back of the eye holds tiny blood vessels and nerve tissue that reveal clues about wider health, often before symptoms appear. NORI's AI will analyse retinal images alongside NHS records and community data, picking up subtle changes that may signal early disease.
The focus is deliberate. People in the North East and North Cumbria face the worst health outcomes in England, with life expectancy up to 10 years shorter in some areas. The approach could later expand to stroke, heart disease and dementia.
Science Minister Chris McDonald visited Sunderland Specialist Eye Hospital to launch NORI. He said: "Sunderland has long been a centre of innovation and scientific endeavour, from glassmaking to shipbuilding, and now in the pioneering use of technology to diagnose illnesses like diabetes and heart disease earlier."
"Earlier diagnosis means better outcomes for patients and less pressure on our NHS, and technology has a vital role to play," McDonald added.
Who is involved?
The hubs bring together engineering and physical sciences experts from all four UK nations, working with the NHS, people with lived experience of the conditions, and healthcare professionals. Partners range from charities — Alzheimer's Society, Dementia UK, Rugby Football League, World Rugby, GB Boxing — to industry names including Nokia, Samsung, Garmin, GE Healthcare, Canon and Jaguar Land Rover, plus the Royal Air Force and the Department of Health and Social Care.
A £1 million contribution from the UKRI Life Science Programme sits within the £52 million total.
Do the hubs have a track record?
Professor Charlotte Deane, Executive Chair of the Engineering and Physical Sciences Research Council, thinks so. "These five new hubs will improve the lives and livelihoods of people and patients right across the UK," she said. "They build on the proven success of our previous hubs, which are already translating cutting-edge research into real benefits, advancing healthcare innovation, including the world's first AI-assisted brain tumour surgery."
"By working closely with patients, the NHS and industry, we're helping people live healthier lives and preventing ill health before it starts," Deane said.
The through-line is shifting care out of hospitals and into communities. If the tools work, a routine eye scan could flag heart risk, a phone could triage a winter cough, and a sideline sensor could judge a tackle's danger in real time. The results, though, depend on trials still to come — the 1,700-patient BRAINIAC rollout is the clearest early test.
via ucl.ac.uk (Original)
More from Nathan Brooks
Show full bio
Market editor covering companies, deals and strategy in general science news at SciBeat.
267 articles
Nearby plates
- £50m centre targets the mysteries of early brain development
- UK Launches £80m Challenge to Speed Up Dementia Diagnosis
- Autonomous AI Freed 2,851 Clinician Hours in Skin Cancer Trial
- Virtual Patients Could Catch Device Risks Real Trials Miss
- Largest cognition genetics study raises rare-variant gene list to 26